Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology

被引:19
|
作者
Kim, Jihoon [1 ]
Koo, Bon-Kyoung [1 ]
Yoon, Ki-Jun [2 ]
机构
[1] Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria
[2] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea
来源
VIRUSES-BASEL | 2019年 / 11卷 / 02期
基金
欧洲研究理事会; 新加坡国家研究基金会;
关键词
organoid; host-virus interactions; CRISPR; Cas9 genome editing; induced pluripotent stem cell; adult stem cell; modeling of viral pathogenesis; LONG-TERM CULTURE; ZIKA-VIRUS; CEREBRAL ORGANOIDS; ROTAVIRUS INFECTION; NEURAL PROGENITORS; HUMAN NOROVIRUSES; DRUG-RESISTANCE; CRISPR-CAS9; IDENTIFICATION; NEUROGENESIS;
D O I
10.3390/v11020124
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pathologies induced by viral infections have undergone extensive study, with traditional model systems such as two-dimensional (2D) cell cultures and in vivo mouse models contributing greatly to our understanding of host-virus interactions. However, the technical limitations inherent in these systems have constrained efforts to more fully understand such interactions, leading to a search for alternative in vitro systems that accurately recreate in vivo physiology in order to advance the study of viral pathogenesis. Over the last decade, there have been significant technological advances that have allowed researchers to more accurately model the host environment when modeling viral pathogenesis in vitro, including induced pluripotent stem cells (iPSCs), adult stem-cell-derived organoid culture systems and CRISPR/Cas9-mediated genome editing. Such technological breakthroughs have ushered in a new era in the field of viral pathogenesis, where previously challenging questions have begun to be tackled. These include genome-wide analysis of host-virus crosstalk, identification of host factors critical for viral pathogenesis, and the study of viral pathogens that previously lacked a suitable platform, e.g., noroviruses, rotaviruses, enteroviruses, adenoviruses, and Zika virus. In this review, we will discuss recent advances in the study of viral pathogenesis and host-virus crosstalk arising from the use of iPSC, organoid, and CRISPR/Cas9 technologies.
引用
收藏
页数:17
相关论文
共 48 条
  • [21] A Simple and Efficient Procedure for Developing Mouse Germline Stem Cell Lines with Gene Knock-in via CRISPR/Cas9 Technology
    Wang, Yang
    Hu, Shuaitao
    Han, Chunsheng
    CURRENT PROTOCOLS, 2024, 4 (09):
  • [22] Modeling sarcoma relevant translocations using CRISPR-Cas9 in human embryonic stem derived mesenchymal precursors
    Vanoli, Fabio
    Antonescu, Cristina R.
    GENES CHROMOSOMES & CANCER, 2023, 62 (09) : 501 - 509
  • [23] Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR/Cas9
    Park, Chul-Yong
    Sung, Jin Jea
    Cho, Sung-Rae
    Kim, Jongwan
    Kim, Dong-Wook
    STEM CELL REPORTS, 2019, 12 (06): : 1242 - 1249
  • [24] Cell-Specific Single Viral Vector CRISPR/Cas9 Editing and Genetically Encoded Tool Delivery in the Central and Peripheral Nervous Systems
    Moffa, Jamie C.
    Bland, India N.
    Tooley, Jessica R.
    Kalyanaraman, Vani
    Heitmeier, Monique
    Creed, Meaghan C.
    Copits, Bryan A.
    ENEURO, 2024, 11 (07)
  • [25] Construction of BHV-1 UL41 Defective Virus Using the CRISPR/Cas9 System and Analysis of Viral Replication Properties
    Dai, Haiyue
    Wu, Jianan
    Yang, Hongshu
    Guo, Yongli
    Di, Haoqing
    Gao, Mingchun
    Wang, Junwei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [26] IRF7-deficient MDCK cell based on CRISPR/Cas9 technology for enhancing influenza virus replication and improving vaccine production
    Mayuramart, Oraphan
    Poomipak, Witthaya
    Rattanaburi, Somruthai
    Khongnomnan, Kritsada
    Anuntakarun, Songtham
    Saengchoowong, Suthat
    Chavalit, Tanit
    Chantaravisoot, Naphat
    Payungporn, Sunchai
    PEERJ, 2022, 10
  • [27] Non-viral Gene Disruption by CRISPR/Cas9 Delivery Using Cell-permeable and Protein-stabilizing 30Kc19 Protein
    Kim, Yu Jin
    Lee, Hyelim
    Cha, Hyeonjin
    Park, Ju Hyun
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2020, 25 (05) : 724 - 733
  • [28] Construction of an IFNAR1 knockout MDBK cell line using CRISPR/Cas9 and its effect on bovine virus replication
    Geng, Yuanchen
    Jiang, Chuanwen
    Yang, Hao
    Xia, Qing
    Xu, Xiaowen
    Yang, Kaihui
    Yuan, Xinwei
    Chen, Jianguo
    Chen, Yingyu
    Chen, Xi
    Zhang, Lei
    Hu, Changmin
    Guo, Aizhen
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Simultaneous Deletion of Virulence Factors and Insertion of Antigens into the Infectious Laryngotracheitis Virus Using NHEJ-CRISPR/Cas9 and Cre-Lox System for Construction of a Stable Vaccine Vector
    Atasoy, Mustafa Ozan
    Rohaim, Mohammed A.
    Munir, Muhammad
    VACCINES, 2019, 7 (04)
  • [30] Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system
    Itoh, Munenari
    Kawagoe, Shiho
    Tamai, Katsuto
    Nakagawa, Hidemi
    Asahina, Akihiko
    Okano, Hirotaka James
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 98 (03) : 163 - 172